Prevalence of anaemia associated with chronic obstructive pulmonary disease: Study of associated variables;Prevalencia de anemia asociada a la enfermedad pulmonar obstructiva crónica: Estudio de las variables asociadas

Archivos de Bronconeumologia

Volumn 49, Issue 9, 2013, Pages 383-387

  Comeche Casanova, Lorena ^a   Echave Sustaeta, Jose María ^a   García Luján, Ricardo ^a   Albarrán Lozano, Irene ^b   Alonso González, Pablo ^c   Llorente Alonso, María Jesús ^d  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

Anaemia; Chronic obstructive pulmonary disease; Erythropoietin; Interleukin; Prevalence

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; FIBRINOGEN; HEMOGLOBIN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; HIGH SENSITIVITY C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANEMIA; ARTICLE; BODY MASS; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSPNEA; FIBRINOGEN BLOOD LEVEL; FORCED EXPIRATORY VOLUME; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; ADULT; DISEASE MARKER; FEMALE; MALE; MIDDLE AGED;

ANAEMIA; ANEMIA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA; ERITROPOYETINA; ERYTHROPOIETIN; INTERLEUCINAS; INTERLEUKIN; PREVALENCE; PREVALENCIA;

AGED; ANEMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; ERYTHROCYTE INDICES; FEMALE; FERRITINS; FIBRINOGEN; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPAIN; TRANSFERRIN;

EID: 84883461682     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2013.04.007     Document Type: Article

References (29)

1. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) Update 2013. Disponible en: http://www.goldcopd.org/.
2. Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185.
3. Gan W.Q., Man S.F.P., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004, 59:574-580.
4. Agustí A.G.N., Noguera A., Sauleda J., Sala E., Pons J., Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003, 21:347-360.
5. John M., Hoernig S., Doehner W., Okonko D.D., Witt C., Anker D.S. Anemia and inflammation in COPD. Chest 2005, 127:825-829.
6. Shorr A.F., Doyle J., Stern L., Dolgister M., Zilberberg M.D. Anemia in chronic obstructive pulmonary disease: Epidemiology and economic implications. Curr Med Res Opin 2008, 24:1123-1130.
7. Cote C., Zilberberg M.D., Mody S.H., Dordelly L.J., Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007, 29:923-929.
8. Watz H., Waschki B., Boehme C., Claussen M., Meyer T., Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity. Am J Respir Crit Care Med 2008, 177:743-751.
9. Boutou A.K., Stanopoulos I., Pitsiou G.G., Kontakiotis T., Kyriazis G., Sichletidis L., et al. Anemia of chronic disease in chronic obstructive pulmonary disease. Respiration 2011, 82:237-245.
10. Portillo K., Belda J., Antón P., Casan P. Alta frecuencia de anemia en pacientes con EPOC ingresados en un hospital de tercer nivel. Rev Clin Esp 2007, 207:383-387.
11. John M., Lange A., Hoernig S., Witt C., Anker S.D. Prevalence of anemia in chronic obstructive pulmonary disease. Comparison to other chronic diseases. Int J Cardiol 2006, 111:365-370.
12. Nowinski A., Kaminski D., Korzybski D., Stoktosa A., Górecka D. The impact of comorbidities on the length of hospital treatment in patients with chronic obstructive pulmonary disease. Pneumonol Alergol Pol 2011, 79:388-396.
13. EuroQol a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. The EuroQol Group.
14. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012.
15. Hsu C.Y., McCulloch C.E., Curhan G.C. Epidemiology of anaemia associated with chronic renal insufficiency among adults in the United States: results from the Triad National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002, 13:504-510.
16. Nutritional anaemia: Report of a WHO scientific Group. WHO Technical Report Series 405 1968, 1-37. World Health Organization, World Health Organization, Geneva, Switzerland.
17. Hall P. The Bootstrap and the Edge worth Expansion 1992, Springer-Verlag, Nueva York.
18. Carpenter J., Bithell J., Swift M.B. Bootstrap confidence intervals: When, which, what? A practical guide for medical statisticians. Stat Med 2000, 19:1141-1164.
19. Drouet M.D., Kotz S. Correlation and Dependence 2001, Imperial College Press, London.
20. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood 2004, 104:2263-2268.
21. Mannino D.M., Thorn D., Swensenm A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008, 32:962-969.
22. Crisafulli E., Costi S., Luppi F., Cirelli G., Cilione C., Coletti O., et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax 2008, 63:487-492.
23. Similowski T., Agustí A., MacNee W., Schönhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J 2006, 27:390-396.
24. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
25. Tassiopoulos S., Kontos A., Konstantopoulos K., Hadzistavrou C., Vaiopoulos G., Aessopos A., et al. Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 2001, 95:471-475.
26. González-Costello J., Comín-Colet J. Iron deficiency and anaemia in heart failure: Understanding the FAIR-HF trial. Eur J Heart Fail 2010, 12:1159-1162.
27. Vlahakos D., Kosmas E., Dimopoulou I., Ikonomou E., Jullien G., Vassilakos P., et al. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am J Med 1999, 106:158-164.
28. Graham R., Celli B., Mannino D.M., Petty T., Rennard S.I., Sciurba F.C., et al. Comorbidities, patient knowledge, and disease management in national sample of patients with COPD. Am J Med 2009, 122:348-355.
29. Tsantes A.E., Tassiopoulos S.T., Papadhimitriou S.I., Bonovas S., Poulakis N., Vlachou A., et al. Theophylline treatment may adversely affect the anoxia-induced erythropoietic response without suppressing erythropoietin production. Eur J Clin Pharmacol 2003, 59:379-383.